Trial Profile
A Randomised, Double-blind, Placebo-controlled Study of the Effect of LIraglutide on Left VEntricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes (The LIVE-study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Chronic heart failure; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LIVE
- 30 Aug 2017 Results of a substudy presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology
- 28 Oct 2016 Primary endpoint has not been met. (Change in Left ventricular function from visit 1 to week 24, measured by Ecco)
- 28 Oct 2016 Results published in the European Journal of Heart Failure